CLINICAL ROLE -
FDA Approves Opdivo for Advanced, Metastatic Bladder Cancer
Opdivo approved as an intravenous treatment for urothelial carcinoma.
Read More
Study Suggests Cannabis' Potential to Treat Opioid Addiction
Although previous reports have cited certain health benefits of cannabinoids, widespread legalization of the substance still faces scrutiny due to a lack of research.
All Things Must Pass
A regular blogger bids farewell for now.
FDA Grants Keytruda Priority Review for Bladder Cancer
Keytruda previously granted breakthrough therapy designation as a second-line treatment for patients with bladder cancer.
Trending News Today: Legislation Targets Manufacturer Drug Coupons
Top news of the day from across the healthcare landscape.
Keytruda Granted Priority Review for 2 New FDA Applications
Keytruda granted priority review as a first- and second- line treatment for bladder cancer.
CDC: Improved HIV Care Needed for African Americans
February 7 marks National Black HIV/AIDS Awareness Day, which promotes awareness of HIV and AIDS and the disparity in care between African Americans in the United States compared to individuals of different races.
Program Promotes Pre-Exposure Prophylaxis Use Among African American Women
African American women account for 62% of women diagnosed with HIV.
Drug Approvals Take 2017 By Storm Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
ASCO Response to Trump Travel Ban Tops Week in Cancer News
Top news of the week in oncology and cancer drug development.
How Does Hiding HIV Infection Impact Adherence?
Study examines whether sharing HIV status has an impact on depression or anxiety symptoms.
Ocrevus Shows Promise Across Forms of Multiple Sclerosis
Ocrelizumab may effectively treat patients with relapsing multiple sclerosis and primary progressive multiple sclerosis.
Investigational Hepatitis C Drug Granted Priority Review
The FDA has accepted AbbVie’s New Drug Application (NDA) for and granted priority review to its investigational, pan-genotype regimen of glecaprevir/pibrentasvir (G/P).
The Future of HIV Highlights Specialty Pharmacy Week in Review
Top articles of the week from Specialty Pharmacy Times.
Nearly Half of Breast Cancer Patients Plagued with Severe Adverse Events
Ninety-three percent of women reported at least 1 adverse event from breast cancer treatment.
New Method to Starve Cancer Cells Discovered
Researchers have found that depleting the environment of arginine plus a glutamine inhibitor may treat multiple types of cancer.
Study Findings May Lead to New Treatment Options for Rheumatoid Arthritis
Scientists used a novel approach for imaging the movement of immune cells in mouse models of RA.
Pembrolizumab Shows Benefit in Mucosal Melanoma
Immunotherapy also found to prolong life in patients with bladder cancer.
Trigger for Joint Inflammation May Lead to New Treatments
Targeting immune cells entering joints may prevent inflammatory arthritis.
No Survival Gains in Postoperative Chemotherapy for Young Patients with Colon Cancer
Young and middle-aged adults with colon cancer are 2 to 8 times more likely to receive postoperative chemotherapy.
Algorithm As Accurate As Dermatologists in Diagnosing Skin Cancer
Computer algorithm for skin cancer matched performance of human dermatologists.
Benefits of Postoperative Chemotherapy in Colon Cancer Questioned
Younger patients with colon cancer are more likely to be administered postoperative chemotherapy.
Starving Cancer Cells May Lead to Less Toxic Treatments
Cancer may be stopped by depriving cells of vital nutrients.
Technology May Improve Memory in Patients with Multiple Sclerosis
Repetitive transcranial magnet stimulation shows promise treating symptoms of MS.
Physicians Largely Oppose Affordable Care Act Repeal
Only 15% of primary care physicians support fully repealing the Affordable Care Act.
Magnetic Stimulation May Improve Memory in Multiple Sclerosis
Working memory was improved in patients with MS who underwent repetitive transcranial magnetic stimulation.
Herpes Vaccine Performs Well in Preclinical Trials
A herpes candidate vaccine was observed to prevent genital lesions, and viral replication.
Late-Onset Hypertension May Protect Against Dementia
Patients diagnosed with hypertension over 80-years-old have a lower risk of developing dementia.
CDC: Fentanyl Overdose Outbreak Reaffirms Need for Naloxone
A particularly dangerous synthetic substance – fentanyl – is increasingly making its way into illicit street drugs and causing drug overdose deaths to skyrocket.
Asthma Drug Reduces Alcohol Cravings, Study Shows
Have scientists found a new drug that could curb alcohol cravings and treat addiction?
